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Abstract
Background: The purpose of this study was to examine the effect of insulin on expression and
synthesis of IGFBP-1 and IGFBP-2 in the baboon endometrium in vitro.
Methods: Baboon endometrial explants collected from cycling, ovariectomized, steroid-treated,
simulated-pregnant and pregnant animals were cultured for 48 h in the presence or absence of
insulin, with or without estradiol, progesterone and hCG.
Results: Insulin clearly inhibited IGFBP-1 production and mRNA expression in a time- and dose-
dependent manner, whereas IGFBP-2 synthesis was not significantly affected. The inhibitory effects
of insulin on IGFBP-1 were more evident in explants of non-pregnant tissue or tissue away from
the implantation site. In the absence of insulin, synthesis of IGFBP-1 was induced in explants with
low levels of de novo synthesis whereas IGFBP-2 synthesis was inhibited. This effect was
potentiated by steroids and hCG in the explant cultures.
Conclusion: Insulin differentially regulates endometrial IGFBP-1 and IGFBP-2 secretion in the
baboon.
Background
The insulin-like growth factor binding proteins (IGFBPs)
include IGFBP-1 and IGFBP-2 that are non-glycosylated,
low molecular weight IGFBPs that have a homologous
amino acid sequence. They are important modulators of
insulin-like growth factor (IGF) bioactivity. In this respect,
IGFBP-1 and IGFBP-2 may potentiate the binding of IGFs
to target cells via integrin receptors by virtue of the fact
that both IGFBP-1 and IGFBP-2 have Arg-Gly-Asp (RGD)
sequences at their C-terminus. The IGFs, IGF-1 and IGF-2,
are mitogens that are involved in the regulation of
endometrial cell proliferation, differentiation and apop-
tosis. Indeed, during the menstrual cycle the mitogenic
effects of estrogen, balanced by the differentiating proper-
ties of progesterone, are mediated by the IGF system. In
the primate, the major sites of synthesis of IGFBP-1 and
IGFBP-2 are the liver and decidualized gestational
endometrium, and the central nervous system, respec-
tively.
During the menstrual cycle IGFBP-1 is a minor secretory
product of the endometrial epithelium and stroma, how-
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ever its production is markedly induced by progesterone
during the late luteal phase [1-6]. Indeed, during preg-
nancy IGFBP-1 becomes the major soluble protein syn-
thesised and secreted by the primate decidual cell [4,7-
10]. Endometrial IGFBP-2 synthesis also increases during
the luteal phase and pregnancy [6] and, similarly, appears
to be induced by progesterone within human endometrial
stromal cells [11,12].
Clinical studies have shown that plasma levels of IGFBP-
1 are rapidly downregulated in response to insulin admin-
istration [13-15]. Furthermore, work on the rat has dem-
onstrated a differential level of induction of hepatic
IGFBP-1 and IGFBP-2 synthesis by insulin deficiency [16].
This in vivo regulation of IGFBP-1 and IGFBP-2 by insulin
has been confirmed by in vitro studies in the rat [17] and
human [11,18-20]. Studies of the liver IGFBP-1 proximal
promoter region have revealed an insulin response
sequence adjacent to the glucocorticoid response element,
and analysis of these DNA sequences has demonstrated
insulin inhibition and glucocorticoid or progesterone
stimulation of IGFBP-1 transcription [21-25].
The earlier studies of the differential inhibitory effects of
insulin on IGFBP-1 and IGFBP-2 gene expression [11,16]
prompted us to examine this further in the primate, using
the baboon as a model. The objective of this study, there-
fore, was to examine the effect of insulin on protein syn-
thesis, secretion and mRNA steady state levels of IGFBP-1
and IGFBP-2 in the baboon endometrium in vitro.
Methods
Tissue samples
Baboon endometrial specimens were obtained from ani-
mals either on day 10 post-ovulation (n = 3), following
ovariectomy (n = 3) and subsequent treatment with ster-
oids (estradiol plus progesterone; [26]), between days 25
and 30 of pregnancy (n = 1) [27], or on days 24 or 25 post-
ovulation (n = 2), following long-term treatment with
steroids [28]. Steroids (Sigma-Aldrich, St. Louis, USA)
were administered via 6 cm silastic implants using one of
the following regimens: either 14 days of estradiol, 14
days of estradiol followed by 14 days of estradiol plus pro-
gesterone, or 14 days of estradiol followed by 14 days of
progesterone [26]. The Animal Care Committee of the
University of Illinois approved all of these experimental
procedures.
Explant culture
Tissue explants (n = 2) of endometrium from the different
treatment groups of baboons were cultured in serum-free
MEM devoid of insulin (Gibco/BRL, Gaithersburg, USA)
over 48 h, controlling for differences in explant weight as
described previously [29]. Explants were cultured in the
presence or absence of 1.5 μM insulin (Sigma-Aldrich, St.
Louis, USA). Some of the baboon explants were also cul-
tured in the presence of the following hormones: estradiol
(36 nM), progesterone (1 μM) and hCG (Profasi; EMD
Serono, Rockland, USA; 0.5 IU/μl). The concentration of
insulin in the complete medium was within physiological
levels [30] whilst the concentrations of estradiol, proges-
terone and hCG were comparable to those assayed in con-
ditioned media from the explant culture of day 25
pregnant baboon placentae [27]. Explant-conditioned
media was harvested and dialysed against 2 mM Tris/HCl
(pH 8.2) to remove the salt and amino acids that would
otherwise interfere with gel electrophoresis and western
blotting, and was replaced with a fresh basal medium at
20–24 h intervals over a short-term culture period of two
days. Protein was quantified following dialysis using the
Lowry method. Equal amounts of protein (50 μg) from
the conditioned media were lyophylised and dissolved in
Laemmli buffer for gel electrophoresis. At the termination
of the culture period, the tissue was immediately rapidly
frozen at -70°C for RNA or protein extraction.
SDS-PAGE, western blotting and immunoassay
Conditioned media from the explant cultures was sepa-
rated by one-dimensional gradient (5–17%) SDS-PAGE
(20–200 μl/lane) under reducing conditions, employing
molecular weight markers, as described previously [7].
Protein loading was checked using Ponceau stain, as
described previously [29]. Gels were stained for 1 h, shak-
ing at room temperature, with 0.1% (wt/vol) Coomassie
brilliant blue in 50% (vol/vol) methanol and destained
prior to western blotting.
Proteins were transferred from the gels to nitrocellulose
membranes by electroblotting, as described previously
[5]. Western blots of the conditioned media harvested
from the explant cultures were first probed with a polyclo-
nal antibody to IGFBP-2 (UBI, Lake Placid, USA) at a titre
of 1:2000, the immunoreactivity being visualized using
alkaline phosphatase. Using the same membranes, they
were then probed with a monoclonal antibody (B2H10) to
IGFBP-1 [10,31] at a titre of 1:2000, the immunoreactivity
being visualized using an enhanced chemiluminescence
kit (Amersham, Arlington Heights, USA). The results from
some blots were semi-quantified using densitometry
[6,32].
Immunoreactive IGFBP-1 in explant culture medium was
assayed using a specific immunoradiometric assay kit
(DSL, Webster, USA). Assays were performed in triplicate.
Extraction of RNA and northern blotting
Total RNA was extracted from the tissue explants follow-
ing short-term (two days) culture using TRI reagent
(Molecular Research Center Inc., Cincinnati, USA). The
concentration and purity of RNA was estimated usingReproductive Biology and Endocrinology 2008, 6:6 http://www.rbej.com/content/6/1/6
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268/28 nm ratios on a spectrophotometer. This RNA (20
μg) was then separated on a 1.2% agarose-formaldehyde
gel and transferred to nitrocellulose. These northern blots
were hybridised at high stringency with 32P-labelled
cDNA probes (1.2 Kp and 795 bp, respectively) to human
IGFBP-1 [10] and IGFBP-2 [33].
Results
Effects of insulin on IGFBP-1 and IGFBP-2 production
In the baboon explant cultures it was found that, gener-
ally, IGFBP-1 and IGFBP-2 production was progesterone-
dependent. However, the synthesis of IGFBP-1 was
inversely proportional to the level of insulin in the culture
medium whereas that of IGFBP-2 was directly propor-
tional to it.
Western blotting of conditioned medium harvested from
explants of endometrium collected from two baboons at
day 10 post-ovulation demonstrates the effect that the
presence or absence of insulin in the culture medium has
on the production of IGFBP-1 and IGFBP-2 (Figure 1). For
IGFBP-1, two bands can be seen at around 32 kD and 19
kD, the latter representing a proteolytic fragment [6,32].
Levels of IGFBP-1 are virtually undetectable in the pres-
ence of insulin whereas they are clearly evident in the
absence of insulin, levels freshly released on day two of
culture being approximately double those on day one
(Figure 1A). Assay of these media samples for immunore-
active IGFBP-1 confirms the western blotting data but
does show that IGFBP-1 is produced in varying amounts
by different explants in the absence of insulin (Figure 1C).
In contrast, IGFBP-2 is detectable whether insulin is
present or absent, levels being higher in the presence of
insulin, but not changing markedly from day one to day
two of culture (Figure 1B).
Western blotting of conditioned medium harvested from
explants of endometrium collected from steroid-treated
ovariectomized baboons demonstrates that the produc-
tion of both IGFBP-1 and IGFBP-2 is induced by proges-
terone, and augmented by estradiol (Figure 2). Again
however, levels of IGFBP-1 are virtually undetectable in
the presence of insulin whereas they are clearly evident in
the absence of insulin (Figure 2A). Assay of these media
samples for immunoreactive IGFBP-1 confirms the west-
ern blotting data and shows the synergistic effect that
estradiol and progesterone have in vivo, particularly when
amplified by the absence of insulin (Figure 2C). Again,
levels of IGFBP-2 are higher in the presence of insulin
(Figure 2B).
Western blotting of conditioned medium harvested from
explants of endometrium (collected from intact, long-
term steroid-treated ovariectomized baboons) exposed to
steroids and hCG in the culture medium demonstrates
that the production of IGFBP-1 is enhanced, but only in
the absence of insulin (Figure 3A). Again, higher levels of
IGFBP-1 were observed on the second day of culture (Fig-
ure 3A), levels of IGFBP-2 being less variable, except in the
absence of insulin where lower levels of IGFBP-2 were
detectable on the second day of culture (Figure 3C). Fur-
thermore, exposure to hCG appeared to inhibit steroid-
induced synthesis and secretion of IGFBP-1 in the absence
of insulin (Figures 3A and 3B).
Western blotting of conditioned medium harvested from
explants of endometrium (either implantation site or
non-implantation site tissue) collected from two baboons
at day 32 of pregnancy, demonstrates the effect that the
presence or absence of insulin in the culture medium has
on the production of IGFBP-1 (Figure 4A) and IGFBP-2
(Figure 4B) is both modulated by pregnancy and is
regionalized. In tissue from pregnant animals IGFBP-1
production is evident even in the presence of insulin, the
inhibitory effect of insulin being less pronounced in tissue
taken from the implantation site, where decidualization
has begun (Figure 4A). Assay of these media samples for
immunoreactive IGFBP-1 confirms the western blotting
data (Figure 4C). Furthermore, a clear inverse dose-
response relationship between the concentration of insu-
lin in the culture medium and the production of IGFBP-1
from non-implantation site tissue can be seen (Figure 5),
and this effect appears to be enhanced after two days of
culture. Again, IGFBP-2 production is decreased in the
absence of insulin, but only in tissue taken from the non-
implantation site (Figure 4B).
Effects of insulin on IGFBP-1 and IGFBP-2 expression
Northern blot analysis of endometrial RNA extracted from
explant tissue (collected from a day 30 pregnant baboon)
cultured with or without insulin and other hormones over
a two-day period confirms that the production of IGFBP-
1 and IGFBP-2 under these conditions is determined by
their expression (Figures 3B &3D). Message for IGFBP-1 is
only evident in the absence of insulin, the level of message
being increased in tissue exposed to steroids and hCG
(Figure 3B). Indeed, following a two-day culture of
endometrial explant tissue a clear inverse dose-response
relationship between the concentration of insulin in the
culture medium and with the level of message for IGFBP-
1 can be seen (Figure 5B). In contrast, message for IGFBP-
2 is present both in the absence and in the presence of
insulin, and the level of message appears to be increased
in tissue that has been exposed to insulin (Figures 3D
&5C).
Discussion
To our knowledge, this is the first full report that charac-
terizes the differential regulation of IGFBP-1 and IGFBP-2
by insulin in the baboon endometrium. We were able toReproductive Biology and Endocrinology 2008, 6:6 http://www.rbej.com/content/6/1/6
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Effect of insulin on IGFBP-1 and IGFBP-2 at day 10 post-ovulation Figure 1
Effect of insulin on IGFBP-1 and IGFBP-2 at day 10 post-ovulation. The effect of insulin (+/- Ins) on IGFBP-1 (BP-1) 
and IGFBP-2 (BP-2) secretion in culture media taken from endometrial explants (n = 2) at day 10 post-ovulation. Media sam-
ples were analysed after 24 h (D-1) and 48 h (D-2) incubation by western blotting for IGFBP-1 (A) and IGFBP-2 (B), and by 
ELISA for IGFBP-1 (C). Values above each band in A and B represent their optical density. PF: Proteolytic fragment of IGFBP-1. 
Open and closed bars in C represent IGFBP-1 levels released by explants from two different animals in the absence of insulin.Reproductive Biology and Endocrinology 2008, 6:6 http://www.rbej.com/content/6/1/6
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Effect of insulin (+/- Ins) on IGFBP-1 and IGFBP-2 secretion in steroid-treated ovariectomized baboons Figure 2
Effect of insulin (+/- Ins) on IGFBP-1 and IGFBP-2 secretion in steroid-treated ovariectomized baboons. 
Endometrial explants (n = 3) were obtained following steroid treatment and incubated in vitro. Media samples were analysed 
by western blotting for IGFBP-1 (A) and IGFBP-2 (B), and by ELISA for IGFBP-1 (C) after 24 h incubation. 14 d E: Treatment 
with estradiol for 14 days; 14 d E+P: Treatment with estradiol for 14 days followed by treatment with estradiol plus progester-
one for 14 days; 14 d P: Treatment with estradiol for 14 days followed by treatment with progesterone alone for 14 days. 
These treatments represent the late follicular, mid secretory and late secretory stages of the cycle, respectively. Values above 
each band in A and B represent their optical density. Open bars: + Insulin; Closed bars: - Insulin.Reproductive Biology and Endocrinology 2008, 6:6 http://www.rbej.com/content/6/1/6
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demonstrate that physiological concentrations of insulin
can inhibit IGFBP-1 production and mRNA expression in
a time- and dose-dependent manner in vitro. As illustrated
in Figure 5, insulin at a dose range from 0.09 μM to 1.5
μM resulted in decreasing levels of immunoreactive pro-
tein and mRNA for IGFBP-1. In contrast, the synthesis of
IGFBP-2 was stimulated in the presence of insulin,
although this increase was not statistically significant.
Conversely, in the absence of insulin, we observed induc-
tion of the in vitro synthesis of IGFBP-1 in tissues exhibit-
ing low levels of de novo synthesis. Vice versa, the synthesis
of IGFBP-2 was inhibited in the absence of insulin.
Effect of insulin and hormones on IGFBP-1 and IGFBP-2 during simulated pregnancy Figure 3
Effect of insulin and hormones on IGFBP-1 and IGFBP-2 during simulated pregnancy. The effect of insulin (+/- Ins) 
and hormones (hCG and/or estradiol and progesterone) on IGFBP-1 (BP-1) and IGFBP-2 (BP-2) synthesis in culture media 
taken from endometrial explants of intact baboons treated long-term (day 24–25) with steroids to simulate pregnancy (n = 2). 
Media and tissue samples were analysed by western and northern blotting for IGFBP-1 (A & B) and IGFBP-2 (C & D), respec-
tively, after 24 h (D-1) and 48 h (D-2) incubation. Values above each band in A and B represent their optical density. PF: Prote-
olytic fragment of IGFBP-1; E: Estradiol; P: Progesterone.Reproductive Biology and Endocrinology 2008, 6:6 http://www.rbej.com/content/6/1/6
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Effect of insulin on IGFBP-1 and IGFBP-2 at the implantation and non-implantation sites Figure 4
Effect of insulin on IGFBP-1 and IGFBP-2 at the implantation and non-implantation sites. The effect of insulin (+/- 
Ins) on IGFBP-1 (BP-1) and IGFBP-2 (BP-2) secretion in culture media taken from endometrial explants of the implantation and 
non-implantation sites of a day 32 pregnant baboon (n = 1). Media samples were analysed by western blotting for IGFBP-1 (A) 
and IGFBP-2 (B), and by ELISA for IGFBP-1 (C) after 24 h (D-1) and 48 h (D-2) incubation. Values above each band in A and B 
represent their optical density. PF: Proteolytic fragment of IGFBP-1. Open bars: + Insulin; Closed bars: - Insulin.Reproductive Biology and Endocrinology 2008, 6:6 http://www.rbej.com/content/6/1/6
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Of particular interest is the relationship between the dif-
ferentiation of endometrial stromal cells to decidual cells,
whereby the endometrium of the menstrual cycle
becomes the decidua of pregnancy, and the change in sen-
sitivity of these tissues to insulin. Although insulin pro-
duced inhibitory effects on IGFBP-1 synthesis in mid-
luteal and progesterone-treated baboon tissues, similar to
those observed with explants from pregnant baboons,
baseline secretory levels of IGFBP-1 were nevertheless
lower than those seen in pregnancy. This demonstrates
that the inhibitory effects of insulin on IGFBP-1 synthesis
are evident prior to decidualization (when decidual cells
begin their synthesis of IGFBP-1). Interestingly, in the
baboon the inhibitory effects of insulin are more evident
in non-pregnant tissue, or in pregnant tissue away from
the implantation site. This suggests that when decidual
synthesis of IGFBP-1 is initiated locally, during the estab-
lishment of pregnancy, the effects of insulin become less
Dose-response effect of insulin on IGFBP-1 in non-implantation endometrium at day 25 of pregnancy Figure 5
Dose-response effect of insulin on IGFBP-1 in non-implantation endometrium at day 25 of pregnancy. The dose-
response effect of insulin on immunoreactive levels of IGFBP-1 in culture media taken from endometrial explants (n = 2) of the 
non-implantation site of a day 25 pregnant baboon. Media and tissue samples were analysed by ELISA for IGFBP-1 (A) after 24 
h (Open bars) and 48 h (Closed bars) incubation, and by northern blotting, respectively, for IGFBP-1 (B) and IGFBP-2 (C).Reproductive Biology and Endocrinology 2008, 6:6 http://www.rbej.com/content/6/1/6
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apparent. Hence, potential paracrine regulatory factors
that influence IGFBP-1 synthesis may be induced and
secreted during pregnancy.
IGFBP-1 is the major secretory product of the decidualized
endometrium and in situ expression of IGFBP-1 mRNA is
most abundant in those decidual cells adjacent to the
invading extravillous trophoblast (EVT), which in contrast
expresses IGF-II mRNA [34]. IGFBP-1 and IGFBP-2 pos-
sess an RGD sequence that can bind to RGD binding sites
on cell surface integrins such as the integrin, α5β1 (also a
receptor for fibronectin), and RGD-α5β1 binding is essen-
tial for the stimulation of trophoblast migration [35-38].
Indeed, it has been suggested that IGFBP-1 and IGF-II can
stabilize each other at the EVT cell surface, potentially
exerting a synergistic effect upon EVT cell migration and
invasion [36,37]. Therefore, our observation in this study
that the inhibitory effect of insulin upon IGFBP-1 secre-
tion is diminished at the implantation site in the baboon
endometrium may have physiological relevance.
Insulin could conceivably play an important role in the
regulation of IGFBP-1 secretion, decidualization and
implantation. In this respect, it has been found that insu-
lin can inhibit IGFBP-1 secretion and gene expression in
human endometrial stromal cells [11,39]. It has also been
shown that cytotrophoblasts plated onto decidual multi-
layers are unable to penetrate the stromal cells unless
decidual IGFBP-1 production is inhibited by insulin [40].
This impedence of trophoblast migration appears to be
mediated by RGD-α5β1 binding since the permissive effect
of insulin may be reversed with exogenous IGFBP-1 but
not with IGFBP-3, which does not possess an RGD
sequence [40]. Also, it appears that the actions of IGFBP-
1 and IGF-II are further regulated by hCG [41-44]. Our
observation of apparent inhibition of steroid-induced
IGFBP-1 synthesis and secretion by hCG in the absence of
insulin is consistent with this, and suggests a mechanism
whereby embryo-derived hCG may conceivably augment
implantation via increased receptivity and angiogenesis
within the endometrium.
The corresponding changes in the levels of immunoreac-
tivity and mRNA for IGFBP-1 and IGFBP-2 observed in
this study indicate that regulation by insulin may occur at
the level of transcription. Hence, changes in production of
IGFBP-1 and IGFBP-2 in response to insulin presumably
may reflect changes in the abundance of their mRNAs.
Therefore, transcriptional or post-transcriptional regula-
tion of IGFBP-1 and IGFBP-2 mRNA abundance may be
crucial to the regulation of IGFs within the endometrium.
In this respect, insulin may co-ordinate the bioactivity of
IGFs with nutritional status through the regulation of
IGFBPs. If so, such a mechanism could be important in
the regulation of trophoblast invasion during implanta-
tion, perhaps particularly so in pathological states such as
intra-uterine growth restriction. The inhibition of
endometrial IGFBP-1 expression by insulin seen in this
study correlates with other studies that have identified an
insulin response sequence in the IGFBP-1 promoter, and
similar phenomena have been observed in other in vitro
systems [17-19,45]. Down-regulation of IGFBP-1 gene
expression by insulin appears to be a phosphatidylinosi-
tol 3-kinase (PI3 kinase) dependent mechanism [46].
One potential pathway downstream of PI3 kinase that has
been proposed to regulate IGFBP-1 mRNA levels involves
activation of protein kinase B/Akt [47]. Through this path-
way, Akt-dependent phosphorylation of two forkhead
transcription factors (Foxo1 and Foxo3) has been shown
to directly inhibit their binding to the insulin response
element in the promoter of the IGFBP-1 gene via their
nuclear exclusion [48-53]. An alternative pathway down-
stream of PI3 kinase, independent of Foxo1 and Foxo3
modulation, has also been proposed to regulate IGFBP-1
gene transcription in response to insulin [54,55]. This
pathway involves the mammalian target of rapamycin, a
protein with a catalytic domain homologous to that of PI3
kinase.
Conclusion
In conclusion, to our knowledge this is the first full report
that confirms in the baboon endometrium the central role
that insulin has in the regulation of IGFBP synthesis, as
reported by others in different experimental models. As
such, this work further demonstrates the value of the
baboon as an experimental model for the human in our
understanding of the events surrounding decidualization,
implantation and pregnancy.
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